JMDC Inc.
Q1 FY2027 IFRS Consolidated Financial Results (Unaudited) [IFRS] (Consolidated)
Consolidated results for the first quarter of the fiscal year ending March 2027 show net sales of 10,605 million yen, operating income of 1,823 million yen, and net income attributable to owners of the parent of 1,132 million yen. Full-year guidance has been revised from the previous announcement. Growth continues in the Health Big Data and telemedicine segments. Cash and cash equivalents total 3,078 million yen, total assets 15,406 million yen, liabilities 7,085 million yen, and equity 8,321 million yen.
Key Figures
- Net sales: 12,605百万円
- Operating profit: 1,823百万円
- Quarterly profit: 1,132百万円
AI要約
Performance trends and segments
For the first quarter-to-date, net sales were 12,605 million yen, up 17.5% year over year. By segment, Health Big Data accounted for 9,201 million yen of external revenue and telemedicine 1,524 million yen. EBITDA was 2,663 million yen, EBITDA margin 21.1%. Health Big Data continues to grow driven by expanded use of health insurance plan data and increased ID counts for Pep Up. Telemedicine benefited from rising demand for imaging interpretation services and expansion of AI-RAD features. Full-year guidance has been revised, with the second half expected to play a key role in overall performance.
Financial position and cash flow
At period end, assets were 154,056 million yen, liabilities 70,851 million yen, and net assets 83,205 million yen. Cash and cash equivalents rose to 30,780 million yen. Operating cash flow was 6,221 million yen, investing activities were negative 968 million yen, and financing activities were negative 3,422 million yen, indicating overall stable cash position. Dividend forecast remains unchanged from the latest announcement. During the period, increases in contract assets and a decrease in accrued income taxes impacted results.
JMDC, Inc.
Company overview · Stock price · Financial data · All IR
